In both January of 2011 & 2012 at ExL Pharma's first and second Clinical CAPAs Events, Dr. Leslie K. Ball, MD, CAPT, USPHS, Acting Director, Division of Scientific Investigations, Office of Compliance, CDER, FDA participated as the keynote speaker and presented FDA/CDER's expectations for the...